Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778979) titled 'Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas' on Aug. 18.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: University of Alabama at Birmingham
Condition:
Glioma
Intervention:
Drug: [18F]FMISO-PET with contrast-enhanced MRI
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07778979
Di...